Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Pharmacological Research|October 26, 2010
Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanismsMatteo Fornai, Rocchina Colucci, Luca Antonioli, et al.
Neuroscience Letters|June 24, 2008
Xenon induces transcription of ADNP in neonatal rat brainDavide Cattano, Simona Valleggi, Daqing Ma, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1Guido Bocci, Anna Fioravanti, Paola Orlandi, et al.
Annali Italiani Di Chirurgia|February 6, 2010
[Colorectal cancer: tissutal explantation and primary cell culture]Roberto Spisni, Alessandra Failli, Giulia Orsini, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|November 19, 2019
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathyMatteo Fornai, Carolina Pellegrini, Laura Benvenuti, et al.
Brain Research Bulletin|April 19, 2005
Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in miceFrancesco Fornai, Paola Lenzi, Michela Ferrucci, et al.
Pharmacological Research|January 10, 2016
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibioticMatteo Fornai, Luca Antonioli, Carolina Pellegrini, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 30, 2010
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptorsLuca Antonioli, Matteo Fornai, Rocchina Colucci, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2013
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?Matteo Fornai, Luca Antonioli, Rocchina Colucci, et al.
Frontiers in Pharmacology|December 19, 2018
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel InflammationCarolina Pellegrini, Matteo Fornai, Rocchina Colucci, et al.
Pageof 5